Welcome to our dedicated page for Alexandria Real Estate Equities news (Ticker: ARE), a resource for investors and traders seeking the latest updates and insights on Alexandria Real Estate Equities stock.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is the largest office REIT specializing in collaborative science and technology campuses situated in urban innovation clusters. Established in 1994, Alexandria has pioneered this niche market, growing a formidable presence in top-tier locations like Greater Boston, San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle Park. The company is renowned for its top-quality, diverse tenant base, which includes life science, agtech, and technology firms.
With a track record of developing Class A properties, Alexandria offers dynamic, collaborative environments that bolster tenant recruitment and retention, creativity, and productivity. Its urban campuses provide tenants with state-of-the-art facilities, including robust lab spaces and strategic amenities designed to enhance innovation and efficiency.
Recent achievements include a public offering of senior notes, with proceeds intended for general corporate purposes and strategic acquisitions, and notable investments from tenants like AstraZeneca for advanced cell therapy manufacturing. Additionally, Alexandria's partnerships extend to major biopharmaceutical companies like Takeda, underscoring its crucial role in supporting groundbreaking research and development.
Financially strong, Alexandria continues to generate substantial net cash from operations, allowing for regular dividend payouts and significant reinvestment into new projects. The company's ability to attract strategic capital through its venture platform underscores its influence in nurturing transformative life sciences and technology ventures.
Alexandria's significance in the REIT sector is further exemplified by its market capitalization of $33.1 billion and an asset base of 73.5 million SF across North America. The company's commitment to sustainability, innovation, and tenant success underscores its status as a leading, mission-driven life science REIT making a lasting positive impact on the world. For more details, visit www.are.com.
On October 18, 2021, Alexandria Venture Investments, a part of Alexandria Real Estate Equities (NYSE: ARE), was named the most active biopharma corporate investor by new deal volume for the fourth consecutive year. The recognition is part of Silicon Valley Bank's Healthcare Investments and Exits: Mid-Year 2021 Report. Alexandria also ranked as the top new Series A investor in biopharma. The firm has a market capitalization of $36.3 billion and has invested in notable companies such as GRAIL and Thrive Earlier Detection, enhancing its role in advancing health science.
On September 30, 2021, Alexandria Real Estate Equities (NYSE: ARE) announced its collaboration with Moderna to develop a new 462,000 RSF headquarters and R&D facility at 325 Binney Street, Cambridge. This cutting-edge building, designed to be the most sustainable laboratory in Cambridge, aims for net-zero energy consumption and various environmental certifications. Construction is underway, with completion expected in 2023, supporting Moderna's growth in mRNA medicines. Alexandria has expanded its asset base to approximately 15 million square feet in Greater Boston, emphasizing its role in the life science ecosystem.
Moderna, Inc. (NASDAQ: MRNA) has announced plans to invest in a new 462,000 sq. ft. science center in
Alexandria Real Estate Equities (NYSE: ARE) announced that OneFifteen, a non-profit healthcare ecosystem for opioid addiction recovery, received an honorable mention in Fast Company's 2021 Innovation by Design Awards. This award highlights Alexandria's role in tackling the opioid crisis, which caused over 95,000 deaths in the U.S. by February 2021. The OneFifteen campus in Dayton, Ohio, developed in partnership with Verily, features comprehensive addiction care and has helped over 3,500 patients since 2019. This recognition emphasizes Alexandria's commitment to innovative solutions in public health.
On September 10, 2021, Alexandria Real Estate Equities (NYSE: ARE) announced that its executive chairman, Joel S. Marcus, received the Distinction in Civic Engagement and Renewal award from the National September 11 Memorial & Museum. This honor recognizes his contributions to the Memorial's mission, particularly in commemorating the victims of the 9/11 attacks. Alexandria will also participate in the 9/11 Tribute in Lights on September 11, lighting up its NYC campus in 'Memorial Blue'. The company maintains a strong commitment to social impact, addressing key societal issues such as health and food insecurity.
Alexandria Real Estate Equities declared a quarterly cash dividend of $1.12 per common share for Q3 2021, payable on October 15, 2021. This brings the total dividend for the year to $4.42, representing a 6 percent increase from the previous year. The funds from operations payout ratio remains low at 60 percent, indicating strong cash management and growth potential. The company continues to invest in its Class A properties, ensuring sustainable growth.
Alexandria Real Estate Equities (NYSE: ARE) will host a conference call and audio webcast on October 26, 2021, at 3:00 p.m. ET to discuss its third quarter operating and financial results. The results will be released after market close on October 25, 2021. Interested participants can join the call by dialing (833) 366-1125 in the U.S. or (412) 902-6738. A replay will be available from 5:00 p.m. ET on October 26, through November 2, 2021. Alexandria specializes in urban office REITs focused on life sciences and technology campuses.
On July 26, 2021, Alexandria Real Estate Equities (ARE) reported strong financial results for Q2 2021. Total revenues increased by 16.6% to $509.6 million, and net income attributable to common stockholders rose to $380.6 million, up from $226.6 million YoY. The company enjoyed historic leasing activity, with 1.9 million RSF leased and rental rate increases of 42.4%. A strong balance sheet was highlighted with $4.5 billion in liquidity, and tenant collections reached 99.4%. Alexandria continues its strategic growth, focusing on life sciences with significant ongoing and future development projects.
FAQ
What is the current stock price of Alexandria Real Estate Equities (ARE)?
What is the market cap of Alexandria Real Estate Equities (ARE)?
What does Alexandria Real Estate Equities, Inc. do?
Where are Alexandria Real Estate properties located?
Who are Alexandria's primary tenants?
What recent achievements has Alexandria Real Estate Equities accomplished?
What is Alexandria's financial condition?
How does Alexandria support innovation?
What is the market capitalization of Alexandria Real Estate Equities?
How does Alexandria contribute to sustainability?
What is Alexandria's venture platform?
Where can I find more information about Alexandria Real Estate Equities?
